These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1850817

  • 1. Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study.
    Ninane J, Perilongo G, Stalens JP, Guglielmi M, Otte JB, Mancini A.
    Med Pediatr Oncol; 1991; 19(3):199-203. PubMed ID: 1850817
    [Abstract] [Full Text] [Related]

  • 2. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
    Ortega JA, Krailo MD, Haas JE, King DR, Ablin AR, Quinn JJ, Feusner J, Campbell JR, Lloyd DA, Cherlow J.
    J Clin Oncol; 1991 Dec; 9(12):2167-76. PubMed ID: 1720452
    [Abstract] [Full Text] [Related]

  • 3. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
    Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW, Vos A, Philips A, Pritchard J, Plaschkes J.
    Cancer; 2000 Oct 15; 89(8):1845-53. PubMed ID: 11042582
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
    Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, Keeling J, Phillips A, Vos A, Plaschkes J.
    J Clin Oncol; 2000 Nov 15; 18(22):3819-28. PubMed ID: 11078495
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Nov 15; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 8. Rationale and results of the International Society of Pediatric Oncology (SIOP) Italian pilot study on childhood hepatoma: surgical resection d'emblée or after primary chemotherapy?
    Guglielmi M, Perilongo G, Cecchetto G, Rondelli R, Lanino E, Siracusa F.
    J Surg Oncol Suppl; 1993 Nov 15; 3():122-6. PubMed ID: 8389158
    [No Abstract] [Full Text] [Related]

  • 9. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
    von Schweinitz D, Bürger D, Weinel P, Mildenberger H.
    Klin Padiatr; 1992 Nov 15; 204(4):214-20. PubMed ID: 1381454
    [Abstract] [Full Text] [Related]

  • 10. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    Cancer; 2003 Apr 15; 97(8):2006-12. PubMed ID: 12673731
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
    Weeda VB, Murawski M, McCabe AJ, Maibach R, Brugières L, Roebuck D, Fabre M, Zimmermann A, Otte JB, Sullivan M, Perilongo G, Childs M, Brock P, Zsíros J, Plaschkes J, Czauderna P, Aronson DC.
    Eur J Cancer; 2013 Aug 15; 49(12):2698-704. PubMed ID: 23683550
    [Abstract] [Full Text] [Related]

  • 13. Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma.
    Schmid I, Häberle B, Albert MH, Corbacioglu S, Fröhlich B, Graf N, Kammer B, Kontny U, Leuschner I, Scheel-Walter HG, Scheurlen W, Werner S, Wiesel T, von Schweinitz D.
    Pediatr Blood Cancer; 2012 Apr 15; 58(4):539-44. PubMed ID: 21922643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    J Clin Oncol; 2002 Jun 15; 20(12):2789-97. PubMed ID: 12065555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.